Description: The group works towards the implementation of these new tools, including next generation sequencing, and the translation to the clinical setting. The aim of the group is the integration of the data obtained in the different research lines to provide more personalized treatments.
research (8551) cancer (3276) spain (2613) españa (2330) genetics (471) salamanca (390) molecular (149) oncohematology (1)
Our group provides support on genetic testing through karyotypic analysis, fluorescence “in situ” hybridization, comparative genomic hybridization, microarrays and next generation sequencing of cancer patients, to more than 100 hospitals in Spain, and occasionally others from the EU.
We collaborate with the most relevant groups in the treatment of the hematological malignancies such as Pethema, GEL-TAMO, GEM or GETH providing technical support and the characterization of the genetic abnormalities in the patients included in clinical trials.
Our main lines research are: